vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $58.8M, roughly 1.4× CBAK Energy Technology, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -12.5%, a 35.3% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 131.8%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $16.1M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -0.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
CBAT vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $85.1M |
| Net Profit | $-7.4M | $19.4M |
| Gross Margin | 7.3% | — |
| Operating Margin | -13.6% | 17.3% |
| Net Margin | -12.5% | 22.8% |
| Revenue YoY | 131.8% | 8508900.0% |
| Net Profit YoY | -63.6% | 139.1% |
| EPS (diluted) | $-0.08 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $85.1M | ||
| Q3 25 | $60.9M | $90.0K | ||
| Q2 25 | $40.5M | $15.0K | ||
| Q1 25 | $34.9M | $14.0K | ||
| Q4 24 | $25.4M | $1.0K | ||
| Q3 24 | $44.6M | $3.0K | ||
| Q2 24 | $47.8M | $5.0K | ||
| Q1 24 | $58.8M | $28.0K |
| Q4 25 | $-7.4M | $19.4M | ||
| Q3 25 | $2.7M | $-56.9M | ||
| Q2 25 | $-3.1M | $-54.7M | ||
| Q1 25 | $-1.6M | $-48.0M | ||
| Q4 24 | $-4.5M | — | ||
| Q3 24 | $17.6K | $-43.8M | ||
| Q2 24 | $6.4M | $-35.0M | ||
| Q1 24 | $9.8M | $-32.4M |
| Q4 25 | 7.3% | — | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 13.7% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 26.6% | — | ||
| Q1 24 | 31.9% | — |
| Q4 25 | -13.6% | 17.3% | ||
| Q3 25 | -6.6% | -67983.3% | ||
| Q2 25 | -8.7% | -396373.3% | ||
| Q1 25 | -8.2% | -383007.1% | ||
| Q4 24 | -26.0% | — | ||
| Q3 24 | -1.9% | -1704400.0% | ||
| Q2 24 | 12.4% | -849120.0% | ||
| Q1 24 | 17.4% | -136200.0% |
| Q4 25 | -12.5% | 22.8% | ||
| Q3 25 | 4.4% | -63195.6% | ||
| Q2 25 | -7.6% | -364386.7% | ||
| Q1 25 | -4.5% | -342657.1% | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | 0.0% | -1461433.3% | ||
| Q2 24 | 13.5% | -699060.0% | ||
| Q1 24 | 16.7% | -115717.9% |
| Q4 25 | $-0.08 | $0.43 | ||
| Q3 25 | $0.03 | $-1.01 | ||
| Q2 25 | $-0.03 | $-0.98 | ||
| Q1 25 | $-0.02 | $-0.86 | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $0.00 | $-0.79 | ||
| Q2 24 | $0.07 | $-0.63 | ||
| Q1 24 | $0.11 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $402.7M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $112.7M | $505.7M |
| Total Assets | $426.2M | $566.7M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $402.7M | ||
| Q3 25 | $10.5M | $305.1M | ||
| Q2 25 | $45.7M | $293.2M | ||
| Q1 25 | $9.6M | $321.4M | ||
| Q4 24 | $11.0M | $424.9M | ||
| Q3 24 | $24.2M | $501.9M | ||
| Q2 24 | $44.1M | $541.9M | ||
| Q1 24 | $23.8M | $525.9M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $4.9M | — | ||
| Q1 25 | $4.1M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $112.7M | $505.7M | ||
| Q3 25 | $121.4M | $369.0M | ||
| Q2 25 | $118.2M | $420.9M | ||
| Q1 25 | $120.8M | $469.7M | ||
| Q4 24 | $121.7M | $510.6M | ||
| Q3 24 | $131.2M | $552.9M | ||
| Q2 24 | $126.6M | $588.3M | ||
| Q1 24 | $120.9M | $600.6M |
| Q4 25 | $426.2M | $566.7M | ||
| Q3 25 | $363.9M | $424.0M | ||
| Q2 25 | $333.1M | $473.6M | ||
| Q1 25 | $311.5M | $515.7M | ||
| Q4 24 | $302.2M | $560.4M | ||
| Q3 24 | $293.5M | $604.0M | ||
| Q2 24 | $279.6M | $620.1M | ||
| Q1 24 | $286.5M | $629.9M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $28.6M |
| Free Cash FlowOCF − Capex | $16.1M | $28.5M |
| FCF MarginFCF / Revenue | 27.3% | 33.5% |
| Capex IntensityCapex / Revenue | 23.4% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $28.6M | ||
| Q3 25 | $14.6M | $-46.5M | ||
| Q2 25 | $13.8M | $-43.4M | ||
| Q1 25 | $-9.6M | $-47.8M | ||
| Q4 24 | $9.6M | $-134.6M | ||
| Q3 24 | $19.7M | $-29.4M | ||
| Q2 24 | $2.9M | $-30.2M | ||
| Q1 24 | $7.4M | $-29.1M |
| Q4 25 | $16.1M | $28.5M | ||
| Q3 25 | $6.0M | $-46.6M | ||
| Q2 25 | $4.1M | $-43.4M | ||
| Q1 25 | $-22.3M | $-48.4M | ||
| Q4 24 | $3.9M | $-138.4M | ||
| Q3 24 | $16.5M | $-31.2M | ||
| Q2 24 | $2.5M | $-30.6M | ||
| Q1 24 | $-454.0K | $-29.8M |
| Q4 25 | 27.3% | 33.5% | ||
| Q3 25 | 9.9% | -51765.6% | ||
| Q2 25 | 10.2% | -289620.0% | ||
| Q1 25 | -63.9% | -345635.7% | ||
| Q4 24 | 15.5% | -13837100.0% | ||
| Q3 24 | 37.1% | -1038966.7% | ||
| Q2 24 | 5.2% | -611840.0% | ||
| Q1 24 | -0.8% | -106421.4% |
| Q4 25 | 23.4% | 0.1% | ||
| Q3 25 | 14.1% | 101.1% | ||
| Q2 25 | 23.8% | 440.0% | ||
| Q1 25 | 36.3% | 4507.1% | ||
| Q4 24 | 22.5% | 378600.0% | ||
| Q3 24 | 7.0% | 59266.7% | ||
| Q2 24 | 0.9% | 6980.0% | ||
| Q1 24 | 13.4% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | 5.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1115.72× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
FDMT
Segment breakdown not available.
